Similar Items: Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Nonlinear mixed-effects modelling of drug-drug interactions between antiretroviral therapy and tuberculosis treatment
- Strategies for optimising TB-HIV co-treatment in children and adolescents with drug-susceptible tuberculosis on rifampicin-based standard regimens
- Performance of host blood transcriptomic signatures for TB diagnosis and monitoring TB treatment
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
Author: Sinanovic, Edina
- Assessment of essential drug management in the public health facilities in Uganda
- A systematic review of the assessment of out-of-pocket payment removal policies in reducing the economic burden caused by direct and indirect costs of HIV service utilization in South Africa
- The Prevalence Of Mental Disorders And Associated Out-Ofpocket Expenditure Among Insured Patients In South Africa
- The change in malaria treatment policy in Uganda : extent of adherence to antimalarial drug policy in Rakai and Kampala Districts
- The economic consequences of COVID-19 on households in low and middle income countries: A mixed method systematic review
- A systematic review of economic evaluations involving childhood obesity